Skip to main content

WOLVERINE ASSET MANAGEMENT LLC

Position in CYTK — Cytokinetics Inc

CIK 1279891 CHICAGO, IL

Position in CYTK

as of Mar 31, 2026 · filed May 4, 2026
Position Value
$7,909
-$341,561 QoQ
Shares Held
120
-97.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CYTK Over Time

Shares Held

Position Value (USD)

Derivatives in CYTK

reported options exposure · as of Dec 31, 2025
CallValue
$0
CallShares
0
PutValue
$317,700
PutShares
5,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

WOLVERINE ASSET MANAGEMENT LLC holds $2,231,368 across 19 Biotechnology names. CYTK ranks #7 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 CYTK
Cytokinetics Inc
This page
120 $7,909

All Filings in CYTK

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,909 120
2025-12-31 $317,700 5,000
2025-12-31 $349,470 5,500
2025-09-30 $274,800 5,000
2025-06-30 $165,200 5,000
2025-03-31 $200,950 5,000
2024-12-31 $235,200 5,000
2024-09-30 $496,320 9,400
2024-06-30 $509,292 9,400
2024-03-31 $1,857,915 26,500
2023-12-31 $6,236,703 74,700
2023-09-30 $1,649,760 56,000
2023-06-30 $1,826,720 56,000
2023-03-31 $1,305,549 37,100
2022-12-31 $3,564,796 77,800
2022-09-30 $1,264,545 26,100